The additive effect of Eldecalcitol for glucocorticoid induced osteoporosis responding poorly to Alendronate.
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Alendronic acid (Primary) ; Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 23 Jun 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 17 Jan 2013 New trial record